Neogen Corp (NEOG) is a publicly traded Healthcare sector company. As of October 26, 2026, NEOG trades at $12.33 with a market cap of $2.66B and a P/E ratio of -299.60. NEOG moved +0.74% today. Year to date, NEOG is +74.39%; over the trailing twelve months it is +100.82%. Its 52-week range spans $3.87 to $14.26. Analyst consensus is buy with an average price target of $14.00. Rallies surfaces NEOG's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Neogen targets adjusted gross margin in high-50% range by FY2031: Neogen targets an adjusted gross margin in the high-50% range and a 30% adjusted EBITDA margin by FY2031. It plans to increase R&D investment by 50% in FY2027, reach 5% of revenue by FY2031, and keep net leverage below 2.5x.
| Metric | Value |
|---|---|
| Price | $12.33 |
| Market Cap | $2.66B |
| P/E Ratio | -299.60 |
| EPS | $-0.04 |
| Dividend Yield | 0.00% |
| 52-Week High | $14.26 |
| 52-Week Low | $3.87 |
| Volume | 236.16K |
| Avg Volume | 0 |
| Revenue (TTM) | $870.40M |
| Net Income | $-7.90M |
| Gross Margin | 46.93% |
3 analysts cover NEOG: 0 strong buy, 2 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $14.00.